Certified by Founder Lodge
SR One Capital Management
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
14 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to
| Company | Date | Round | Raised |
|---|---|---|---|
 Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
 Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
 Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Poplar Therapeutics |
January, 09 ,2026 | Series A | $50,000,000 |
| Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Mission Therapeutics |
March, 15 ,2024 | Unknown | $32,101,650 |
| Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
| Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
| Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
| Poplar Therapeutics |
January, 09 ,2026 | Series A | $50,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Allos | $5,000,000 | (Jan 14, 2026)
PayMedix | $33,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
